16 March 2023>: Articles
A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis
Unusual or unexpected effect of treatment, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathologyAdebola Oluwabusayo Adetiloye B* , Farhana Alladin E , Rasha Alaameri E , Julio C. Valencia-Manrique E , Olurotimi Badero E , Armeen Poor E
Am J Case Rep 2023; 24:e938359
Figure 4. Chest X-ray at 7 months of Itraconazole therapy showing marked decrease in left upper-lobe opacities.